1 - 25 of 140 results for author:"Ueda S." in Literature citations
Results Customize
› Repeat search in UniProtKB (17,200)
| Toxicogenomic biomarkers for renal papillary injury in rats. Uehara T., Kondo C., Morikawa Y., Hanafusa H., Ueda S., Minowa Y., Nakatsu N., Ono A., Maruyama T., Kato I. et al. Toxicology 303:1-8(2013) · Mapped (8) |
| Two serine phosphorylation sites in the C-terminus of Rad9 are critical for 9-1-1 binding to TopBP1 and activation of the DNA damage checkpoint response in HeLa cells. Ueda S., Takeishi Y., Ohashi E., Tsurimoto T. Genes Cells 17:807-816(2012) · Mapped (5) |
| Levels of the oxidative stress marker gamma-glutamyltranspeptidase at different stages of nonalcoholic fatty liver disease. Irie M., Sohda T., Iwata K., Kunimoto H., Fukunaga A., Kuno S., Yotsumoto K., Sakurai K., Iwashita H., Hirano G. et al. J. Int. Med. Res. 40:924-933(2012) · Mapped (9) |
| Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy. Wakabayashi Y., Usui Y., Okunuki Y., Ueda S., Kimura K., Muramatsu D., Kezuka T., Goto H. Invest. Ophthalmol. Vis. Sci. 53:6403-6410(2012) · Mapped (6) |
| Purification and biochemical characterization of a novel ecto-apyrase, MP67, from Mimosa pudica. Okuhata R., Takishima T., Nishimura N., Ueda S., Tsuchiya T., Kanzawa N. Plant Physiol. 157:464-475(2011) · UniProtKB (6) |
| Colorimetric inorganic pyrophosphate assay using a double cycling enzymatic method. Sakasegawa S., Hayashi J., Ikura Y., Ueda S., Imamura S., Kumazawa T., Nishimura A., Ohshima T., Sakuraba H. Anal. Biochem. 416:61-66(2011) |
| Significance of plasma NT-proBNP levels as a biomarker in the assessment of cardiac involvement and pulmonary hypertension in patients with sarcoidosis. Handa T., Nagai S., Ueda S., Chin K., Ito Y., Watanabe K., Tanizawa K., Tamaya M., Mishima M., Izumi T. Sarcoidosis Vasc Diffuse Lung Dis 27:27-35(2010) · Mapped (1) |
| Evaluation of ERCC1 expression for cisplatin sensitivity in human hepatocellular carcinoma. Ueda S., Shirabe K., Morita K., Umeda K., Kayashima H., Uchiyama H., Soejima Y., Taketomi A., Maehara Y. Ann. Surg. Oncol. 18:1204-1211(2011) · Mapped (4) |
| Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patients. Nagano M., Fukami K., Yamagishi S., Sakai K., Kaida Y., Matsumoto T., Hazama T., Tanaka M., Ueda S., Okuda S. Nephrology (Carlton) 16:299-303(2011) · Mapped (2) |
| Sustained upregulation of sodium taurocholate cotransporting polypeptide and bile salt export pump and downregulation of cholesterol 7alpha-hydroxylase in the liver of patients with end-stage primary biliary cirrhosis. Takeyama Y., Kanegae K., Inomata S., Takata K., Tanaka T., Ueda S., Yokoyama K., Morihara D., Nishizawa S., Anan A. et al. Med Mol Morphol 43:134-138(2010) · Mapped (10) |
| The p66shc gene expression in peripheral blood monocytes is increased in patients with coronary artery disease. Noda Y., Yamagishi S., Matsui T., Ueda S., Ueda S., Jinnouchi Y., Hirai Y., Imaizumi T. Clin Cardiol 33:548-552(2010) · Mapped (5) |
| Ephexin4 and EphA2 mediate cell migration through a RhoG-dependent mechanism. Hiramoto-Yamaki N., Takeuchi S., Ueda S., Harada K., Fujimoto S., Negishi M., Katoh H. J. Cell Biol. 190:461-477(2010) · UniProtKB (6) · Mapped (7) |
| Is structural remodeling of fibrillated atria the consequence of tissue hypoxia? Ogi H., Nakano Y., Niida S., Dote K., Hirai Y., Suenari K., Tonouchi Y., Oda N., Makita Y., Ueda S. et al. Circ. J. 74:1815-1821(2010) · Mapped (22) |
| Lack of collagen XVIII/endostatin exacerbates immune-mediated glomerulonephritis. Hamano Y., Okude T., Shirai R., Sato I., Kimura R., Ogawa M., Ueda Y., Yokosuka O., Kalluri R., Ueda S. J. Am. Soc. Nephrol. 21:1445-1455(2010) · Mapped (4) |
| Crucial role of the small GTPase Rac1 in insulin-stimulated translocation of glucose transporter 4 to the mouse skeletal muscle sarcolemma. Ueda S., Kitazawa S., Ishida K., Nishikawa Y., Matsui M., Matsumoto H., Aoki T., Nozaki S., Takeda T., Tamori Y. et al. FASEB J. 24:2254-2261(2010) · Mapped (7) |
| Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis. Kobayashi T., Tsuda H., Moriya T., Yamasaki T., Kikuchi R., Ueda S., Omata J., Yamamoto J., Matsubara O. Breast Cancer Res. Treat. 123:733-745(2010) · Mapped (2) |
| Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93. Ueda S.M., Mao T.L., Kuhajda F.P., Vasoontara C., Giuntoli R.L., Bristow R.E., Kurman R.J., Shih I.e.M. Am. J. Pathol. 175:2618-2624(2009) · Mapped (3) |
| Comparable effects of moderate intensity exercise on changes in anorectic gut hormone levels and energy intake to high intensity exercise. Ueda S.Y., Yoshikawa T., Katsura Y., Usui T., Fujimoto S. J. Endocrinol. 203:357-364(2009) · Mapped (2) |
| Irbesartan inhibits advanced glycation end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression. Matsui T., Yamagishi S., Takeuchi M., Ueda S., Fukami K., Okuda S. Pharmacol. Res. 61:34-39(2010) · Mapped (36) |
| Impaired vascular development in the yolk sac and allantois in mice lacking RA-GEF-1. Kanemura H., Satoh T., Bilasy S.E., Ueda S., Hirashima M., Kataoka T. Biochem. Biophys. Res. Commun. 387:754-759(2009) · Mapped (10) |
| Regulation of mitotic spindle formation by the RhoA guanine nucleotide exchange factor ARHGEF10. Aoki T., Ueda S., Kataoka T., Satoh T. BMC Cell Biol. 10:56-56(2009) · Mapped (2) |
| Factors associated with serum high mobility group box 1 (HMGB1) levels in a general population. Fukami A., Adachi H., Yamagishi S., Matsui T., Ueda S., Nakamura K., Enomoto M., Otsuka M., Kumagae S., Nanjo Y. et al. Metab. Clin. Exp. 58:1688-1693(2009) · Mapped (41) |
| Dorsal telencephalon-specific RA-GEF-1 knockout mice develop heterotopic cortical mass and commissural fiber defect. Bilasy S.E., Satoh T., Ueda S., Wei P., Kanemura H., Aiba A., Terashima T., Kataoka T. Eur. J. Neurosci. 29:1994-2008(2009) · Mapped (5) |
| Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock. Nakamura T., Sato E., Fujiwara N., Kawagoe Y., Suzuki T., Ueda Y., Yamada S., Shoji H., Takeuchi M., Ueda S. et al. Pharmacol. Res. 60:515-518(2009) · Mapped (5) |
| Pigment epithelium-derived factor (PEDF) inhibits diabetes- or advanced glycation end product (AGE)-induced platelet CD40 ligand overexpression in rats. Yamagishi S., Matsui T., Ueda S., Takeuchi M. Int. J. Cardiol. 144:283-285(2010) · Mapped (1) |